Trial Profile
Humoral and cellular immune response against tetanus and diphtheria following booster vaccination
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; DTaP vaccine
- Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics; Registrational
- 09 Jul 2011 Based on the results from this trial, the vaccine was approved by the US FDA for use in subjects aged 65 years or older.
- 02 Jun 2011 New trial record